Two Sigma Securities, LLC United Therapeutics Corp Put Options Transaction History

Two Sigma Securities, LLC

10 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	SELL	$311.04 - $363.55 $5.82 Million - $6.8 Million	-18,700 Reduced 82.74%	3,900 $1.4 Million
Q2 2024 Aug 14, 2024	BUY	$228.26 - $319.04 $3.4 Million - $4.75 Million	14,900 Added 193.51%	22,600 $7.2 Million
Q1 2024 May 15, 2024	BUY	$210.76 - $249.51 $1.62 Million - $1.92 Million	7,700 New	7,700 $1.77 Million
Q3 2023 Nov 14, 2023	BUY	$211.82 - $248.24 $211,820 - $248,240	1,000 New	1,000 $225,000
Q1 2023 May 15, 2023	SELL	$212.99 - $276.17 $766,764 - $994,212	-3,600 Reduced 80.0%	900 $201,000
Q4 2022 Feb 14, 2023	BUY	$205.95 - $280.43 $926,775 - $1.26 Million	4,500 New	4,500 $1.25 Million
Q4 2020 Feb 16, 2021	SELL	$101.87 - $151.79 $224,114 - $333,938	-2,200 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$99.9 - $121.13 $219,780 - $266,486	2,200 New	2,200 $222,000
Q2 2019 Aug 14, 2019	SELL	$76.06 - $120.81 $220,574 - $350,349	-2,900 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$107.15 - $126.84 $310,735 - $367,836	2,900 New	2,900 $340,000

671

42.3M

194K

295K

Ticker UTHR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,516,300
Market Cap $16.4B
Description
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...

Get notified when there are updates to the investment portfolio of Two Sigma Securities, LLC, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Securities, LLC with notifications on news.